Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to market Tretinoin Cream USP, 0.1%, (USRLD: Retin-A Cream, 0.1%). Tretinoin cream is used to treat acne. The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India).

Tretinoin Cream USP, 0.1% had annual sales of USD 54.8 million in the United States (IQVIA MAT Feb-24). The group now has 394 approvals and has so far filed over 460* ANDAs since the commencement of the filing process in Fiscal Year 2003-04.